Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/avidity-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302179319.html
https://www.prnewswire.com/news-releases/avidity-biosciences-partners-with-the-fshd-society-to-raise-awareness-of-facioscapulohumeral-muscular-dystrophy-on-world-fshd-day-302176199.html
https://www.prnewswire.com/news-releases/avidity-biosciences-inc-announces-closing-of-upsized-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302174637.html
https://www.prnewswire.com/news-releases/avidity-biosciences-inc-announces-pricing-of-public-offering-of-common-stock-302172616.html
https://www.fiercebiotech.com/biotech/aviditys-rna-therapy-safe-shows-possible-functional-benefit-phase-12-muscular-dystrophy
https://www.prnewswire.com/news-releases/avidity-biosciences-inc-announces-proposed-public-offering-of-common-stock-302171257.html
https://www.prnewswire.com/news-releases/avidity-biosciences-to-present-preliminary-data-from-phase-12-fortitude-trial-of-aoc-1020-in-people-living-with-facioscapulohumeral-muscular-dystrophy-at-31st-annual-fshd-society-international-research-congress-302158556.html
https://www.prnewswire.com/news-releases/avidity-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302151659.html
https://www.prnewswire.com/news-releases/avidity-biosciences-announces-appointment-of-simona-skerjanec-to-board-of-directors-302145638.html
https://www.prnewswire.com/news-releases/avidity-biosciences-reports-first-quarter-2024-financial-results-and-recent-highlights-302141622.html